<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02215382</url>
  </required_header>
  <id_info>
    <org_study_id>Odu-3</org_study_id>
    <nct_id>NCT02215382</nct_id>
  </id_info>
  <brief_title>Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular Blockade</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>T.C. ORDU ÜNİVERSİTESİ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>T.C. ORDU ÜNİVERSİTESİ</source>
  <brief_summary>
    <textblock>
      The aim of this study, comparison of effects of sugammadex versus neostigmine/atropine
      combination on hemodynamic parameters and intraocular pressure during tracheal extubation.

      This prospective, randomised study was designed to compare two reversal methods with respect
      to changes in IOP, heart rate and blood pressure during tracheal extubation period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraocular pressure</measure>
    <time_frame>baseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>baseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>baseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Intraocular Pressure Changes During Tracheal Extubation</condition>
  <arm_group>
    <arm_group_label>sugammadex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>neostigmine + atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sugammadex</intervention_name>
    <description>sugammadex 2 mg/kg</description>
    <arm_group_label>sugammadex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>neostigmine+atropine</intervention_name>
    <description>neostigmine 0,05 mg/kg + atropine 0,025 mg/kg</description>
    <arm_group_label>neostigmine + atropine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II physical status

          -  elective surgery

          -  endotracheal intubation under general anesthesia

        Exclusion Criteria:

          -  emergency surgery

          -  pregnancy

          -  laparoscopic surgery

          -  prone position

          -  BMI &gt; 30 kg/m2

          -  sedative drug use in last month

          -  patients with glaucoma.

          -  ASA &gt; II physical status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital</name>
      <address>
        <city>Altınordu</city>
        <state>Ordu</state>
        <zip>52100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2014</study_first_submitted>
  <study_first_submitted_qc>August 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2014</study_first_posted>
  <last_update_submitted>April 18, 2015</last_update_submitted>
  <last_update_submitted_qc>April 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>T.C. ORDU ÜNİVERSİTESİ</investigator_affiliation>
    <investigator_full_name>özgür yağan</investigator_full_name>
    <investigator_title>MD, assistant professor</investigator_title>
  </responsible_party>
  <keyword>two reversal methods</keyword>
  <keyword>changes in IOP</keyword>
  <keyword>heart rate</keyword>
  <keyword>blood pressure</keyword>
  <keyword>tracheal extubation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

